Skip to content
Recall Observatory FDA recall evidence

Drug product

Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01

D-1214-2018

August 23, 2018

Class III

Product summary

Firm
LUPIN SOMERSET
Event
Event 80874
Status
Terminated
Classification
Class III
Quantity
4716 bottle
Official record key
drug-enforcement:D-1214-2018

Official wording

Reason: Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.

Code information: Lot# S800232, Exp 2/20

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of Specification